Annual Non Current Assets
$57.97 M
+$53.43 M+1178.78%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual long term assets is $57.97 million, with the most recent change of +$53.43 million (+1178.78%) on December 1, 2023.
- ORMP annual non current assets is now at all-time high.
Performance
ORMP Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$22.31 M
-$8.65 M-27.93%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly long term assets is $22.31 million, with the most recent change of -$8.65 million (-27.93%) on September 1, 2024.
- Over the past year, ORMP quarterly non current assets has dropped by -$35.66 million (-61.52%).
- ORMP quarterly non current assets is now -61.52% below its all-time high of $57.97 million, reached on December 1, 2023.
Performance
ORMP Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ORMP Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1178.8% | -61.5% |
| 3 y3 years | - | -18.6% |
| 5 y5 years | +4229.1% | +1565.9% |
ORMP Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1178.8% | -61.5% | +423.0% |
| 5 y | 5-year | at high | +4229.1% | -61.5% | +5590.6% |
| alltime | all time | at high | -100.0% | -61.5% | -100.0% |
Oramed Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.31 M(-27.9%) |
| Jun 2024 | - | $30.95 M(+16.6%) |
| Mar 2024 | - | $26.56 M(-54.2%) |
| Dec 2023 | $162.58 M(+3.5%) | $57.97 M(+5.0%) |
| Sep 2023 | - | $55.19 M(+932.7%) |
| Jun 2023 | - | $5.34 M(+15.6%) |
| Mar 2023 | - | $4.62 M(+2.0%) |
| Dec 2022 | $157.11 M(+6.2%) | $4.53 M(+6.3%) |
| Sep 2022 | - | $4.26 M(-84.4%) |
| Jun 2022 | - | $27.42 M(-4.3%) |
| Mar 2022 | - | $28.66 M(-4.8%) |
| Dec 2021 | $147.94 M(+55.2%) | - |
| Nov 2021 | - | $30.12 M(-7.8%) |
| Aug 2021 | $95.34 M(+135.3%) | $32.66 M(+295.5%) |
| May 2021 | - | $8.26 M(+97.3%) |
| Feb 2021 | - | $4.18 M(-15.4%) |
| Nov 2020 | - | $4.95 M(+20.0%) |
| Aug 2020 | $40.51 M(+21.6%) | $4.12 M(-15.0%) |
| May 2020 | - | $4.85 M(+1137.8%) |
| Feb 2020 | - | $392.00 K(-2.0%) |
| Nov 2019 | - | $400.00 K(-70.1%) |
| Aug 2019 | $33.32 M(+7.4%) | $1.34 M(-87.7%) |
| May 2019 | - | $10.84 M(-11.2%) |
| Feb 2019 | - | $12.21 M(-12.4%) |
| Nov 2018 | - | $13.94 M(-14.8%) |
| Aug 2018 | $31.04 M(+52.9%) | $16.36 M(+47.7%) |
| May 2018 | - | $11.08 M(-35.3%) |
| Feb 2018 | - | $17.13 M(-23.6%) |
| Nov 2017 | - | $22.41 M(+21.7%) |
| Aug 2017 | $20.30 M(-35.0%) | $18.41 M(+37.0%) |
| May 2017 | - | $13.44 M(+11.5%) |
| Feb 2017 | - | $12.06 M(-16.5%) |
| Nov 2016 | - | $14.43 M(+24.4%) |
| Aug 2016 | $31.23 M(+79.8%) | $11.60 M(+3.9%) |
| May 2016 | - | $11.16 M(-9.5%) |
| Feb 2016 | - | $12.34 M(+41.9%) |
| Nov 2015 | - | $8.70 M(-3.2%) |
| Aug 2015 | $17.37 M | $8.98 M(+86.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2015 | - | $4.83 M(+3.0%) |
| Feb 2015 | - | $4.68 M(>+9900.0%) |
| Nov 2014 | - | $27.00 K(+12.5%) |
| Aug 2014 | $21.78 M(+151.9%) | $24.00 K(-99.6%) |
| May 2014 | - | $6.53 M(>+9900.0%) |
| Feb 2014 | - | $23.10 K(+20.3%) |
| Nov 2013 | - | $19.20 K(+20.0%) |
| Aug 2013 | $8.64 M(+63.8%) | $16.00 K(-28.9%) |
| May 2013 | - | $22.50 K(+25.7%) |
| Feb 2013 | - | $17.90 K(+5.3%) |
| Nov 2012 | - | $17.00 K(-7.6%) |
| Aug 2012 | $5.28 M(+23.2%) | $18.40 K(+16.5%) |
| May 2012 | - | $15.80 K(-53.9%) |
| Feb 2012 | - | $34.30 K(-7.5%) |
| Nov 2011 | - | $37.10 K(-11.5%) |
| Aug 2011 | $4.28 M(+206.7%) | $41.90 K(+28.5%) |
| May 2011 | - | $32.60 K(-43.2%) |
| Feb 2011 | - | $57.40 K(+18.1%) |
| Nov 2010 | - | $48.60 K(-10.2%) |
| Aug 2010 | $1.40 M(-56.0%) | $54.10 K(-13.2%) |
| May 2010 | - | $62.30 K(-12.7%) |
| Feb 2010 | - | $71.40 K(-10.3%) |
| Nov 2009 | - | $79.60 K(-9.0%) |
| Aug 2009 | $3.17 M(-41.2%) | $87.50 K(-6.9%) |
| May 2009 | - | $94.00 K(-5.5%) |
| Feb 2009 | - | $99.50 K(-4.3%) |
| Nov 2008 | - | $104.00 K(-4.7%) |
| Aug 2008 | $5.40 M(+179.7%) | $109.10 K(+4.9%) |
| May 2008 | - | $104.00 K(+15.6%) |
| Feb 2008 | - | $90.00 K(+542.9%) |
| Nov 2007 | - | $14.00 K(+100.0%) |
| Aug 2007 | $1.93 M(+995.3%) | $7000.00(>+9900.0%) |
| May 2007 | - | $0.00(0.0%) |
| Feb 2007 | - | $0.00(0.0%) |
| Nov 2006 | - | $0.00(0.0%) |
| Aug 2006 | $176.20 K(>+9900.0%) | $0.00(0.0%) |
| May 2006 | - | $0.00 |
| Aug 2005 | $1300.00 | - |
FAQ
- What is Oramed Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual non current assets year-on-year change?
- What is Oramed Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly non current assets year-on-year change?
What is Oramed Pharmaceuticals annual long term assets?
The current annual non current assets of ORMP is $57.97 M
What is the all time high annual non current assets for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual long term assets is $57.97 M
What is Oramed Pharmaceuticals annual non current assets year-on-year change?
Over the past year, ORMP annual long term assets has changed by +$53.43 M (+1178.78%)
What is Oramed Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of ORMP is $22.31 M
What is the all time high quarterly non current assets for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly long term assets is $57.97 M
What is Oramed Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, ORMP quarterly long term assets has changed by -$35.66 M (-61.52%)